See every side of every news story

Published 1 day ago • loading... • Updated 1 day ago

Brokerages Set Beam Therapeutics Inc. (NASDAQ:BEAM) Target Price at $47.67

Summary by Com-unik.info

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been given an average recommendation of “Buy” by the twelve research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Brokerages Set Beam Therapeutics Inc. (NASDAQ:BEAM) Target Price at $47.67

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been given an average recommendation of “Buy” by the twelve research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating […]

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated1 day agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

com-unik.info broke the news in 1 day ago on Thursday, February 20, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics